(资料图)
Xu Kunlin, governor of Jiangsu, met in Nanjing on Thursday afternoon with Gu Kunbo, member of the executive board of Merck Group and CEO of medical and health business.
Xu Kunlin welcomed Gu Kunbo for his visit to Jiangsu, adding that Germany is an important trading partner of Jiangsu with many German multinational enterprises reporting good momentum in Jiangsu and injecting impetus and vitality into the development of China-Germany relations.
He said Jiangsu has attached great importance to the development of the pharmaceutical industry and has included it in the key cultivation of strategic emerging industries and advanced manufacturing clusters in the province.
The governor hoped that Merck Group would continue to give full play to its own advantages by combining with Jiangsu"s development strategy, industrial foundation and scientific research strength, strengthen exchanges and cooperation with scientific research institutes and high-tech enterprises, lay out more innovative resources and high-quality projects, implement and transform more leading technological achievements, participate in the construction of the supply chain, innovation chain and industrial chain, and achieve high-level mutual benefit and win-win results.
Xu Kunlin said Jiangsu will continue to provide better services and create better conditions, helping to coordinate and solve the difficulties and problems encountered in production and operation.
Gu Kunbo thanked Jiangsu for its strong support for the development of Merck Group over the years. He said that Merck Group has a long history of presence in the Chinese market and has enjoyed a special and close relationship with China, in particular with Jiangsu.
We will continue to further unleash the production capacity of our factories in Jiangsu, actively integrate into the development of the emerging biopharmaceutical industry, and make greater contributions to promoting the province"s high-quality development and improving people"s health and well-being.
标签: